MOP

MPay Of Macau Pass Rose Over 200% In Transaction Value And Volume In Japan's Cross-Border Payments In 2024 Q1

Retrieved on: 
Wednesday, April 10, 2024
Growth, Finance, Macau Pass, Somatosensory system, Travel, MOP, QR, Statistics, News, EZ-Link, Public Bank Berhad, KakaoPay, Digital technology, GCash, Naver Pay, Marketing, Cryptocurrency

Japan is one of the first countries where MPay has launched cross-border payment services through Alipay+ and is also one of the favorite travel destinations for residents of Macao.

Key Points: 
  • Japan is one of the first countries where MPay has launched cross-border payment services through Alipay+ and is also one of the favorite travel destinations for residents of Macao.
  • Currently, people from Macao can use MPay to make purchases at cooperating stores in Japan, settle in MOP, and enjoy preferential exchange rates.
  • According to statistics, in the first quarter of 2024, MPay's transaction volume and number of transactions in Japan increased by over 200% respectively compared to the fourth quarter of 2023.
  • By working with these partners, Alipay+ provides global tourists with the same seamless digital payment experience they enjoy in their own markets.

AM Best Affirms Credit Ratings of China Taiping Insurance (Macau) Company Limited

Retrieved on: 
Thursday, March 21, 2024
Insurance, Professional Services, Risk management, Communication, ALL, News, MOP, Seemabaddha, Bank statement, Credit, China Taiping Insurance Holdings, AM Best, USD

AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a” (Excellent) of China Taiping Insurance (Macau) Company Limited (CTIM) (Macau).

Key Points: 
  • AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a” (Excellent) of China Taiping Insurance (Macau) Company Limited (CTIM) (Macau).
  • CTIM’s underwriting portfolio and distribution channels are stable and diversified, while the company continues to develop its online channel and explore cross-selling opportunities in its affiliated life insurance company, China Taiping Life Insurance (Macau) Company Limited, in Macau.
  • A weakening credit profile of the parent company, China Taiping Insurance Holdings Company Limited, also may have a negative impact on CTIM’s ratings.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings .

Sands China Honours Suppliers and SMEs at Sands Supplier Excellence Awards and Sands Procurement Academy Graduation

Retrieved on: 
Monday, January 22, 2024
Transfer, The Parisian Macao, Liaison Office, Social responsibility, Stock exchange, SME, LVS, Commerce, Knowledge, Cotai Arena, Las Vegas Sands, Walking, Growth, MOP, Cotai, Transport, Restaurant, Economy, Cotai Water Jet, Tourism, Macao Daily News, Cayman, Casino

MACAO, Jan. 22, 2024 /PRNewswire/ -- Sands China Ltd. recognised some of its most outstanding suppliers at the Sands Supplier Excellence Awards Jan. 19 at The Londoner® Macao. The awards were part of a joint event where Sands China also honoured the 13th and 14th cohorts of local SMEs graduating from its Sands Procurement Academy training programme, highlighted some of the success stories of Sands China's ongoing partnerships with its local SME suppliers, and held a cocktail and business networking session to connect local SME suppliers with representatives from various Sands China departments, including the procurement and supply chain team.

Key Points: 
  • With Sands China holding the academy's graduation ceremony together at one event with the Sands Supplier Excellence Awards, the graduating SMEs are able to gain encouragement and inspiration by seeing local SMEs among those getting awarded by Sands China as outstanding suppliers.
  • At Friday's graduation ceremony, Sands China recognised 69 local SMEs for completing the academy's training programme.
  • Friday's event concluded with the graduates of the Sands Procurement Academy attending a cocktail and business networking session, where they met representatives from various Sands China departments, as well as procurement team members from Las Vegas Sands, Sands China, and Marina Bay Sands.
  • Sands China had a total procurement spend of MOP 8.4 billion in 2023, with 26 percent going to local SMEs.

DESelect Launches Marketing Optimization Platform

Retrieved on: 
Thursday, November 30, 2023
Segment, Marketing, Intelligence, Machine learning, MOP

AUSTIN, Texas, Nov. 30, 2023 /PRNewswire/ -- DESelect announced the launch of the DESelect Marketing Optimization Platform (MOP), to help marketing teams maximize the effectiveness and efficiency of their campaigns.

Key Points: 
  • AUSTIN, Texas, Nov. 30, 2023 /PRNewswire/ -- DESelect announced the launch of the DESelect Marketing Optimization Platform (MOP), to help marketing teams maximize the effectiveness and efficiency of their campaigns.
  • The DESelect Marketing Optimization Platform brings together DESelect's global products, including Segment, Engage, Search, and Deedee AI to provide clients with a mission control center for improving marketing effectiveness.
  • Founder and CEO Anthony Lamot commented, "It's exciting to establish the Marketing Optimization Platform as an entirely new product category to meet our clients' needs.
  • DESelect's Marketing Optimization Platform is available to all clients globally, with features based on their current plan tier.

DESelect Launches Marketing Optimization Platform

Retrieved on: 
Thursday, November 30, 2023
Segment, Marketing, Intelligence, Machine learning, MOP

AUSTIN, Texas, Nov. 30, 2023 /PRNewswire/ -- DESelect announced the launch of the DESelect Marketing Optimization Platform (MOP), to help marketing teams maximize the effectiveness and efficiency of their campaigns.

Key Points: 
  • AUSTIN, Texas, Nov. 30, 2023 /PRNewswire/ -- DESelect announced the launch of the DESelect Marketing Optimization Platform (MOP), to help marketing teams maximize the effectiveness and efficiency of their campaigns.
  • The DESelect Marketing Optimization Platform brings together DESelect's global products, including Segment, Engage, Search, and Deedee AI to provide clients with a mission control center for improving marketing effectiveness.
  • Founder and CEO Anthony Lamot commented, "It's exciting to establish the Marketing Optimization Platform as an entirely new product category to meet our clients' needs.
  • DESelect's Marketing Optimization Platform is available to all clients globally, with features based on their current plan tier.

Combined Therapeutics to Present at 11th International mRNA Health Conference

Retrieved on: 
Wednesday, October 25, 2023
Plasma, IND, MPH, Therapy, Vaccine, Antigen, Biotechnology, Conference, MOP, Cell, Protein, Engineering, Combined, Tissue, COVID-19, CTX, Messenger, File, Infection, Safety, Cancer, Pharmaceutical industry

BOSTON, Oct. 25, 2023 /PRNewswire/ -- Combined Therapeutics Inc. (CTx), a privately held biotechnology company developing the next generation of mRNA therapeutics with a novel modified-mRNA platform to treat and prevent infectious diseases and cancer, today announced the participation of Romain Micol, M.D., MPH, Ph.D., President and CEO of Combined Therapeutics, as a speaker at the 11th International mRNA Health Conference, taking place Oct. 31-Nov. 2, 2023, in Berlin, Germany.

Key Points: 
  • Dr. Romain Micol, President and Chief Executive Officer, will provide an update on Combined Therapeutics' proprietary MOPCTx mRNA platform, which controls where the protein is expressed.
  • BOSTON, Oct. 25, 2023 /PRNewswire/ -- Combined Therapeutics Inc. (CTx), a privately held biotechnology company developing the next generation of mRNA therapeutics with a novel modified-mRNA platform to treat and prevent infectious diseases and cancer, today announced the participation of Romain Micol, M.D., MPH, Ph.D., President and CEO of Combined Therapeutics, as a speaker at the 11th International mRNA Health Conference, taking place Oct. 31-Nov. 2, 2023, in Berlin, Germany.
  • "CTx's participation in the 11th Annual International mRNA Health Conference provides a valuable opportunity to share and discuss the latest advancements in mRNA medicines development with leaders in the space," said Dr. Micol.
  • For more information about the 11th International mRNA Health Conference, please visit its website at https://www.mrna-conference.com/ .

Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Investigational Pain Therapy Cebranopadol at the 2023 PAINWeek Conference

Retrieved on: 
Tuesday, September 5, 2023
Health, Neurology, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Ketan, Pharma, Naloxone, Oxycodone, Food and Drug Administration, Opioid use disorder, ADHD, DSM-IV codes, OUD, VAS, FQ, Physical dependence, II, Pain, Visual analogue scale, NOP, Patient, Risk, MOP, Neuropathic pain, Pain management, Addiction, Drug, HAP, FDA, Tramadol, Food, Pharmaceutical industry, Tris

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on ADHD, pain and neurological disorders, today announced new data from a human abuse potential (HAP) study of cebranopadol (TRN-228) which suggest the investigational compound has significantly lower abuse potential compared to both schedule II and schedule IV opioids.

Key Points: 
  • Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on ADHD, pain and neurological disorders, today announced new data from a human abuse potential (HAP) study of cebranopadol (TRN-228) which suggest the investigational compound has significantly lower abuse potential compared to both schedule II and schedule IV opioids.
  • The findings will be shared on Thursday, September 7, in a poster presentation at the 2023 PAINWeek conference in Las Vegas.
  • Study participants randomly received a single dose of placebo, cebranopadol 600 μg, cebranopadol 1000 μg, tramadol IR 600 mg or oxycodone IR 40 mg.
  • The difference between the good effects and bad effects of drugs have been linked to their abuse potential.

AM Best Affirms Credit Ratings of Macau Insurance Company Limited

Retrieved on: 
Thursday, August 31, 2023
Insurance, Professional Services, Communication, AM Best, MIC, ALL, COVID-19, Risk management, Credit, Investment, MOP, AM, C&S, News

AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Macau Insurance Company Limited (MIC) (Macau).

Key Points: 
  • AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Macau Insurance Company Limited (MIC) (Macau).
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings .
  • For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments .
  • AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry.

Tris Pharma Awarded Five-Year Grant of Up to $16.6M From the NIH's National Institute on Drug Abuse to Advance Cebranopadol for the Treatment of Opioid Use Disorder

Retrieved on: 
Monday, August 28, 2023
Research, Mental Health, Neurology, Clinical Trials, Other Health, Biotechnology, Pharmaceutical, Health, Science, Other Science, Ketan, Pharma, Wayne State University, Opioid, Public, Initiative, ADHD, DSM-IV codes, Opioid use disorder, OUD, FQ, Heroin, Bangladesh Technical Education Board, Pain, Cocaine, NOP, National Institute on Drug Abuse, MOP, NIDA, Pain management, Drug, Schedule 2, FDA, NIH, Disease, Pharmaceutical industry, Tris

Through the Helping to End Addiction Long-term® Initiative (NIH HEAL Initiative®), NIH has awarded grants to fund the optimization of new therapies to prevent and treat opioid use disorder (OUD).

Key Points: 
  • Through the Helping to End Addiction Long-term® Initiative (NIH HEAL Initiative®), NIH has awarded grants to fund the optimization of new therapies to prevent and treat opioid use disorder (OUD).
  • Cebranopadol is an investigational, dual nociception/orphanin FQ peptide (NOP) receptor and µ-opioid peptide (MOP) receptor agonist.
  • Further, cebranopadol has demonstrated reduced cocaine and heroin self-administration and drug-seeking behaviors, reinforcing its potential as an effective treatment for OUD.
  • The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Potash Emerges as an Important Component for Global Food Production

Retrieved on: 
Tuesday, August 15, 2023
The Mosaic Company, Intrepid, Blue Diamond Growers, Mineral, Intrepid Potash, Food, Bed, NTR, Magnesium, ICL, Agriculture, Water, Port, Nutrient, FOB, Hydrochloride, Cory, Port of Vancouver (1964–2008), Neptune, Nutrien, USD, ILWU, Sulfur, KCI, EBITDA, International Longshore and Warehouse Union, MOP, Mining, Potassium chloride, United States Department of Justice Environment and Natural Resources Division, IPI, ICL Group Ltd., Potassium, Salt, CFS, NYSE, News, DAP, Financial News, Potash, Canpotex, Phosphate, Mosaic, Paradox Basin

NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Potash is used in a wide variety of areas and most commonly refers to a group of potassium-rich minerals and chemicals. It is the vital ingredient to produce fertilizer and is widely used in the agricultural industry to boost crop yields and support plant growth. The most common type of potash is Muriate of Potash (MOP) derived from potassium chloride (KCI). It accounts for approximately 95% of the global agricultural potash. Potash also helps to improve the quality of crops by enhancing their flavor, color, and texture. As a result, the market value projections for potash are positive, with the global demand for potash expected to increase due to the growing population and the need for increased food production. Overall, according to data published by the Business Research Company, the global potash market size will grow from USD 22.04 Billion in 2022 to USD 23.03 Billion in 2023, while at a compound annual growth rate (CAGR) of 4.5%. Sage Potash Corp. (TSX-V: SAGE), The Mosaic Company (NYSE: MOS), Intrepid Potash, Inc. (NYSE: IPI), Nutrien Ltd. (NYSE: NTR), ICL Group Ltd. (NYSE: ICL)

Key Points: 
  • The most common type of potash is Muriate of Potash (MOP) derived from potassium chloride (KCI).
  • As a result, the market value projections for potash are positive, with the global demand for potash expected to increase due to the growing population and the need for increased food production.
  • "The disruption at the Port of Vancouver has resulted in the curtailment of production at our Cory potash mine and if prolonged could also impact production at our other potash mines in Saskatchewan.
  • ICL Group is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the food, agriculture and industrial markets.